Shenzhen Bioeasy Biotechnology Co Ltd
300942
Company Profile
Business description
Shenzhen Bioeasy Biotechnology Co Ltd is dedicated towards food and drug safety, clinical diagnosis, public safety and other fields. It produces and sells clinical diagnosis products. It develops testing products for nine areas closely related to people's lives which include food safety, agricultural product safety, dairy product safety, meat safety, aquatic product safety, honey safety, clinical diagnosis, drug safety, and public safety.
Contact
Liuxian 1st Road, Xin'an Street
101, Yirui Biological Building, Xingdong Community
Bao'an District, Guangdong Province
Shenzhen518101
CHNT: +86 75529744527
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
480
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,954.60 | 8.90 | -0.10% |
CAC 40 | 7,800.88 | 33.70 | -0.43% |
DAX 40 | 23,970.36 | 247.14 | -1.02% |
Dow JONES (US) | 44,837.56 | 64.36 | -0.14% |
FTSE 100 | 9,081.44 | 38.87 | -0.43% |
HKSE | 25,295.21 | 266.92 | -1.04% |
NASDAQ | 21,178.58 | 70.27 | 0.33% |
Nikkei 225 | 40,599.19 | 399.08 | -0.97% |
NZX 50 Index | 12,936.41 | 25.67 | 0.20% |
S&P 500 | 6,389.77 | 1.13 | 0.02% |
S&P/ASX 200 | 8,693.40 | 4.30 | -0.05% |
SSE Composite Index | 3,596.11 | 1.83 | -0.05% |